Skip to content

Role of mindfulness meditation as moderating variable in reducing death anxiety

Gagan Jain

Mortality July 25, 2023 DOI: 10.1080/13576275.2023.2230149 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 42
Population Adults (25 male, 17 female) during the COVID-19 pandemic
Intervention Mindfulness meditation
Dose 20 minutes
Topics Anxiety Meditation
Key findings Mindfulness meditation significantly reduced death anxiety in the experimental group relative to the control group, indicating that a brief 20-minute meditation practice may moderate death anxiety during a period of heightened death salience.

Abstract

ABSTRACT The widespread mortality caused by the second wave of COVID created a sense of death salience world over. Past literature suggests that reminder of one’s own mortality produces death anxiety in a person. The present study intends to see the effect of mindfulness meditation as a moderating variable on death anxiety. For this, the participants (n = 42; 25 male, 17 female) were randomly assigned to the control and the experimental groups. The experimental group practiced 20 minutes of mindfulness meditation while the control group received no such intervention. It has been found that there was a significant impact of mindfulness meditation on the experimental group in reducing death anxiety.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics